Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis

You'll see two new treatment options for moderate to severe plaque psoriasis, Otezla (apremilast) and Cosentyx (secukinumab).

About 20% of psoriasis patients need systemic meds added to topicals.

Be aware of the extra interactions, side effects, and monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote